EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. INSM

Equity Profile

INSM

Insmed Incorporated

Health CareBiotechnology$21.9B market cap

Earnings scorecard

Last 75Q

EPS beat streak

2Q

EPS beat rate

20%

Avg EPS surprise

-13.67%

Avg 1-day reaction

-1.05%

Earnings history

76 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 29, 2026————Preview
Q2-2026Aug 6, 2026$-0.69$-0.06+91.32%+33.86%Preview
Q1-2026May 7, 2026$-0.99$-0.76+15.84%-23.41%Preview
Q4-2025Feb 19, 2026$-1.07$-1.54-43.79%+6.54%Preview
Q3-2025Oct 30, 2025$-1.32$-1.75-32.68%+16.33%Preview
Q2-2025Aug 7, 2025ProPreview
Q1-2025May 8, 2025ProPreview
Q4-2024Feb 20, 2025ProPreview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Aug 8, 2024ProPreview
Q1-2024May 9, 2024ProPreview
Q4-2023Feb 22, 2024ProPreview
Q3-2023Oct 26, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023May 4, 2023ProPreview
Q4-2022Feb 23, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 5, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020Apr 30, 2020ProPreview
Q4-2019Feb 25, 2020ProPreview
Q3-2019Oct 30, 2019ProPreview
Q2-2019Aug 1, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 22, 2019ProPreview
Q3-2018Oct 30, 2018ProPreview
Q2-2018Aug 2, 2018ProPreview
Q1-2018May 2, 2018ProPreview
Q4-2017Feb 23, 2018ProPreview
Q3-2017Nov 2, 2017ProPreview
Q2-2017Aug 3, 2017ProPreview
Q1-2017May 3, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Nov 6, 2015ProPreview
Q2-2015Aug 6, 2015ProPreview
Q1-2015May 7, 2015ProPreview
Q4-2014Feb 27, 2015ProPreview
Q3-2014Nov 6, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014May 8, 2014ProPreview
Q4-2013Mar 6, 2014ProPreview
Q3-2013Nov 5, 2013ProPreview
Q2-2013Aug 6, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Mar 18, 2013ProPreview
Q3-2012Nov 7, 2012ProPreview
Q2-2012Aug 7, 2012ProPreview
Q1-2012May 8, 2012ProPreview
Q4-2011Mar 13, 2012ProPreview
Q3-2011Nov 8, 2011ProPreview
Q2-2011Aug 8, 2011ProPreview
Q1-2011May 10, 2011ProPreview
Q3-2010Nov 3, 2010ProPreview
Q2-2010Aug 4, 2010ProPreview
Q1-2010May 6, 2010ProPreview
Q4-2009Mar 15, 2010ProPreview
Q3-2009Nov 6, 2009ProPreview
Q2-2009Aug 13, 2009ProPreview
Q1-2009May 13, 2009ProPreview
Q4-2008Mar 11, 2009ProPreview
Q3-2008Oct 30, 2008ProPreview
Q2-2008Aug 8, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 4, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview

Next report

Q3-2026

Thu, Oct 29

Before the open

Est. EPS

—

Est. Rev

—

Read the preview

About INSM

Sector
Health Care
Industry
Biotechnology
Market cap
$21.9B

71 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 7, 2025ProPreview
Q1-2025May 8, 2025ProPreview
Q4-2024Feb 20, 2025Pro
Preview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Aug 8, 2024ProPreview
Q1-2024May 9, 2024ProPreview
Q4-2023Feb 22, 2024ProPreview
Q3-2023Oct 26, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023May 4, 2023ProPreview
Q4-2022Feb 23, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 5, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020Apr 30, 2020ProPreview
Q4-2019Feb 25, 2020ProPreview
Q3-2019Oct 30, 2019ProPreview
Q2-2019Aug 1, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 22, 2019ProPreview
Q3-2018Oct 30, 2018ProPreview
Q2-2018Aug 2, 2018ProPreview
Q1-2018May 2, 2018ProPreview
Q4-2017Feb 23, 2018ProPreview
Q3-2017Nov 2, 2017ProPreview
Q2-2017Aug 3, 2017ProPreview
Q1-2017May 3, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Nov 6, 2015ProPreview
Q2-2015Aug 6, 2015ProPreview
Q1-2015May 7, 2015ProPreview
Q4-2014Feb 27, 2015ProPreview
Q3-2014Nov 6, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014May 8, 2014ProPreview
Q4-2013Mar 6, 2014ProPreview
Q3-2013Nov 5, 2013ProPreview
Q2-2013Aug 6, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Mar 18, 2013ProPreview
Q3-2012Nov 7, 2012ProPreview
Q2-2012Aug 7, 2012ProPreview
Q1-2012May 8, 2012ProPreview
Q4-2011Mar 13, 2012ProPreview
Q3-2011Nov 8, 2011ProPreview
Q2-2011Aug 8, 2011ProPreview
Q1-2011May 10, 2011ProPreview
Q3-2010Nov 3, 2010ProPreview
Q2-2010Aug 4, 2010ProPreview
Q1-2010May 6, 2010ProPreview
Q4-2009Mar 15, 2010ProPreview
Q3-2009Nov 6, 2009ProPreview
Q2-2009Aug 13, 2009ProPreview
Q1-2009May 13, 2009ProPreview
Q4-2008Mar 11, 2009ProPreview
Q3-2008Oct 30, 2008ProPreview
Q2-2008Aug 8, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 4, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview